Guiding TRAIL to cancer cells through Kv10.1 potassium channel overcomes resistance to doxorubicin
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1017
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Guiding TRAIL to cancer cells through Kv10.1 potassium channel overcomes resistance to doxorubicin ; day:27 ; month:6 ; year:2016 ; pages:1-11
European biophysics journal ; (27.6.2016), 1-11
- Creator
-
Hartung, Franziska
- Contributor
-
Pardo, Luis A.
SpringerLink (Online service)
- DOI
-
10.1007/s00249-016-1149-7
- URN
-
urn:nbn:de:1111-2016062813266
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hartung, Franziska
- Pardo, Luis A.
- SpringerLink (Online service)
Other Objects (12)
A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia
Stress-induced TRAILR2 expression overcomes TRAIL resistance in cancer cell spheroids
Choline kinase alpha impairment overcomes TRAIL resistance in ovarian cancer cells
Doxorubicin and etoposide sensitize small cell lung carcinoma cells expressing caspase-8 to TRAIL
Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia
Tongue trail to kidney
HuR inhibition overcomes cFLIP-mediated doxorubicin resistance in triple-negative breast cancer
On the trail to Sacramento
On the trail to Benguet
Targeting KPNB1 overcomes TRAIL resistance by regulating DR5, Mcl-1 and FLIP in glioblastoma cells
CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR
PP2A inhibition overcomes acquired resistance to HER2 targeted therapy
A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia
Stress-induced TRAILR2 expression overcomes TRAIL resistance in cancer cell spheroids
Choline kinase alpha impairment overcomes TRAIL resistance in ovarian cancer cells
Doxorubicin and etoposide sensitize small cell lung carcinoma cells expressing caspase-8 to TRAIL
Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia
Tongue trail to kidney
HuR inhibition overcomes cFLIP-mediated doxorubicin resistance in triple-negative breast cancer
On the trail to Sacramento
On the trail to Benguet
Targeting KPNB1 overcomes TRAIL resistance by regulating DR5, Mcl-1 and FLIP in glioblastoma cells
CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR
PP2A inhibition overcomes acquired resistance to HER2 targeted therapy
A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia
Stress-induced TRAILR2 expression overcomes TRAIL resistance in cancer cell spheroids
Choline kinase alpha impairment overcomes TRAIL resistance in ovarian cancer cells
Doxorubicin and etoposide sensitize small cell lung carcinoma cells expressing caspase-8 to TRAIL
Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia
Tongue trail to kidney
HuR inhibition overcomes cFLIP-mediated doxorubicin resistance in triple-negative breast cancer
On the trail to Sacramento
On the trail to Benguet
Targeting KPNB1 overcomes TRAIL resistance by regulating DR5, Mcl-1 and FLIP in glioblastoma cells
CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR